PT  - JOURNAL ARTICLE
AU  - Heather Parr
AU  - David S Sanders
TI  - Cui bono? PEG feeding
AID  - 10.7861/clinmed.2020-0759
DP  - 2021 Jan 01
TA  - Clinical Medicine
PG  - e2--e4
VI  - 21
IP  - 1
4099  - http://www.rcpjournals.org/content/21/1/e2.short
4100  - http://www.rcpjournals.org/content/21/1/e2.full
SO  - Clin Med2021 Jan 01; 21
AB  - Percutaneous endoscopic gastrostomy (PEG) provides long-term nutritional support to those unable to tolerate intake orally. The benefits of a PEG depend on the indication and the individual, and are considered when it has the potential to improve mortality, nutritional status or quality of life. Often, family members and healthcare professionals have to act on behalf of the patient. It is difficult for their personal values and emotions to not be a factor when deciding if to proceed with a PEG. This may result in unnecessary PEG placement. For certain indications (dementia for example), there is limited evidence of any benefits a PEG may give and may actually cause harm. Guidance to improve patient selection and increase education for healthcare professionals is essential in achieving the best outcome for the patient.